Industry Research Reports

Home > Reports > Chemical & Material > Global Finasteride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Global Finasteride API Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031

Industry: Chemical & Material

Published Date: 2025-02-15

Pages: 95 Pages

Report ld: 3945855

Request Sample

Customized Report

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

Description
Table of Contents
Table of Figures
Related Reports
PDF Download

The global Finasteride API market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.

Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

The global Finasteride API market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Finasteride API market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2020-2031.

MARKET SEGMENTATION

By Company

AMRI
Mylan
Accord Pharmaceuticals
Sterling Spa
DEAFARMA
Gadea Grupo Farmacéutico, S.L.U.
Hetero
Dr.Reddys Laboratories
Pharmaffiliates
Cipla
Henan Topfond
Khonsu International
Aurobindo Pharma

Consumption by Region

North America
- United States
- Canada
Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
Latin America
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA

Segment by Type

Abrove 99% Purity
99% Purity
Under 99% Purity

Segment by Application

Pharmaceutical Industry
Research Organization
Others

biaoTi CHAPTER OUTLINE

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Sales and revenue of Finasteride API in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region.

Chapter 3: Detailed analysis of Finasteride API manufacturers competitive landscape, sales, revenue, price, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Region analysis by company, by customer, by Type, by Application, sales, revenue, and price for each segment,

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Finasteride API revenue, gross margin, and recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Sales channels analysis

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

biaoTi QYRESEARCH'S STRENGTHS

Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:

Market entry risks/opportunities by region

We identify regional market threats and growth prospects to guide your overseas layout.

Product mix optimization based on local practices

We adjust product portfolios in line with local consumption habits.

Competitor tactics in fragmented vs. consolidated markets

We unpack rivals’ operation strategies for scattered and highly concentrated industries.

Full Research Coverage

We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.

19 Years Industry Expertise

We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.

24/7 Fast Report Delivery

Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.

Localized Strategic Analysis

We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.

Market entry risks/opportunities by region

All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.

Market entry risks/opportunities by region

We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.

TABLE OF CONTENTS

1 Market Overview

1.1 Finasteride API Product Scope

1.2 Finasteride API by Type

1.2.1 Global Finasteride API Sales by Type (2020 & 2024 & 2031)

1.2.2 Abrove 99% Purity

1.2.3 99% Purity

1.2.4 Under 99% Purity

1.3 Finasteride API by Application

1.3.1 Global Finasteride API Sales Comparison by Application (2020 & 2024 & 2031)

1.3.2 Pharmaceutical Industry

1.3.3 Research Organization

1.3.4 Others

1.4 Global Finasteride API Market Estimates and Forecasts (2020-2031)

1.4.1 Global Finasteride API Market Size in Value Growth Rate (2020-2031)

1.4.2 Global Finasteride API Market Size in Volume Growth Rate (2020-2031)

1.4.3 Global Finasteride API Price Trends (2020-2031)

1.5 Assumptions and Limitations

2 Market Size and Prospective by Region

2.1 Global Finasteride API Market Size by Region: 2020 VS 2024 VS 2031

2.2 Global Finasteride API Retrospective Market Scenario by Region (2020-2025)

2.2.1 Global Finasteride API Sales Market Share by Region (2020-2025)

2.2.2 Global Finasteride API Revenue Market Share by Region (2020-2025)

2.3 Global Finasteride API Market Estimates and Forecasts by Region (2026-2031)

2.3.1 Global Finasteride API Sales Estimates and Forecasts by Region (2026-2031)

2.3.2 Global Finasteride API Revenue Forecast by Region (2026-2031)

2.4 Major Region and Emerging Market Analysis

2.4.1 North America Finasteride API Market Size and Prospective (2020-2031)

2.4.2 Europe Finasteride API Market Size and Prospective (2020-2031)

2.4.3 China Finasteride API Market Size and Prospective (2020-2031)

2.4.4 Japan Finasteride API Market Size and Prospective (2020-2031)

3 Global Market Size by Type

3.1 Global Finasteride API Historic Market Review by Type (2020-2025)

3.1.1 Global Finasteride API Sales by Type (2020-2025)

3.1.2 Global Finasteride API Revenue by Type (2020-2025)

3.1.3 Global Finasteride API Price by Type (2020-2025)

3.2 Global Finasteride API Market Estimates and Forecasts by Type (2026-2031)

3.2.1 Global Finasteride API Sales Forecast by Type (2026-2031)

3.2.2 Global Finasteride API Revenue Forecast by Type (2026-2031)

3.2.3 Global Finasteride API Price Forecast by Type (2026-2031)

3.3 Different Types Finasteride API Representative Players

4 Global Market Size by Application

4.1 Global Finasteride API Historic Market Review by Application (2020-2025)

4.1.1 Global Finasteride API Sales by Application (2020-2025)

4.1.2 Global Finasteride API Revenue by Application (2020-2025)

4.1.3 Global Finasteride API Price by Application (2020-2025)

4.2 Global Finasteride API Market Estimates and Forecasts by Application (2026-2031)

4.2.1 Global Finasteride API Sales Forecast by Application (2026-2031)

4.2.2 Global Finasteride API Revenue Forecast by Application (2026-2031)

4.2.3 Global Finasteride API Price Forecast by Application (2026-2031)

4.3 New Sources of Growth in Finasteride API Application

5 Competition Landscape by Players

5.1 Global Finasteride API Sales by Players (2020-2025)

5.2 Global Top Finasteride API Players by Revenue (2020-2025)

5.3 Global Finasteride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride API as of 2024)

5.4 Global Finasteride API Average Price by Company (2020-2025)

5.5 Global Key Manufacturers of Finasteride API, Manufacturing Sites & Headquarters

5.6 Global Key Manufacturers of Finasteride API, Product Type & Application

5.7 Global Key Manufacturers of Finasteride API, Date of Enter into This Industry

5.8 Manufacturers Mergers & Acquisitions, Expansion Plans

6 Region Analysis

6.1 North America Market: Players, Segments, Downstream and Major Customers

6.1.1 North America Finasteride API Sales by Company

6.1.1.1 North America Finasteride API Sales by Company (2020-2025)

6.1.1.2 North America Finasteride API Revenue by Company (2020-2025)

6.1.2 North America Finasteride API Sales Breakdown by Type (2020-2025)

6.1.3 North America Finasteride API Sales Breakdown by Application (2020-2025)

6.1.4 North America Finasteride API Major Customer

6.1.5 North America Market Trend and Opportunities

6.2 Europe Market: Players, Segments, Downstream and Major Customers

6.2.1 Europe Finasteride API Sales by Company

6.2.1.1 Europe Finasteride API Sales by Company (2020-2025)

6.2.1.2 Europe Finasteride API Revenue by Company (2020-2025)

6.2.2 Europe Finasteride API Sales Breakdown by Type (2020-2025)

6.2.3 Europe Finasteride API Sales Breakdown by Application (2020-2025)

6.2.4 Europe Finasteride API Major Customer

6.2.5 Europe Market Trend and Opportunities

6.3 China Market: Players, Segments, Downstream and Major Customers

6.3.1 China Finasteride API Sales by Company

6.3.1.1 China Finasteride API Sales by Company (2020-2025)

6.3.1.2 China Finasteride API Revenue by Company (2020-2025)

6.3.2 China Finasteride API Sales Breakdown by Type (2020-2025)

6.3.3 China Finasteride API Sales Breakdown by Application (2020-2025)

6.3.4 China Finasteride API Major Customer

6.3.5 China Market Trend and Opportunities

6.4 Japan Market: Players, Segments, Downstream and Major Customers

6.4.1 Japan Finasteride API Sales by Company

6.4.1.1 Japan Finasteride API Sales by Company (2020-2025)

6.4.1.2 Japan Finasteride API Revenue by Company (2020-2025)

6.4.2 Japan Finasteride API Sales Breakdown by Type (2020-2025)

6.4.3 Japan Finasteride API Sales Breakdown by Application (2020-2025)

6.4.4 Japan Finasteride API Major Customer

6.4.5 Japan Market Trend and Opportunities

7 Company Profiles and Key Figures

7.1 AMRI

7.1.1 AMRI Company Information

7.1.2 AMRI Business Overview

7.1.3 AMRI Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.1.4 AMRI Finasteride API Products Offered

7.1.5 AMRI Recent Development

7.2 Mylan

7.2.1 Mylan Company Information

7.2.2 Mylan Business Overview

7.2.3 Mylan Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.2.4 Mylan Finasteride API Products Offered

7.2.5 Mylan Recent Development

7.3 Accord Pharmaceuticals

7.3.1 Accord Pharmaceuticals Company Information

7.3.2 Accord Pharmaceuticals Business Overview

7.3.3 Accord Pharmaceuticals Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.3.4 Accord Pharmaceuticals Finasteride API Products Offered

7.3.5 Accord Pharmaceuticals Recent Development

7.4 Sterling Spa

7.4.1 Sterling Spa Company Information

7.4.2 Sterling Spa Business Overview

7.4.3 Sterling Spa Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.4.4 Sterling Spa Finasteride API Products Offered

7.4.5 Sterling Spa Recent Development

7.5 DEAFARMA

7.5.1 DEAFARMA Company Information

7.5.2 DEAFARMA Business Overview

7.5.3 DEAFARMA Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.5.4 DEAFARMA Finasteride API Products Offered

7.5.5 DEAFARMA Recent Development

7.6 Gadea Grupo Farmacéutico, S.L.U.

7.6.1 Gadea Grupo Farmacéutico, S.L.U. Company Information

7.6.2 Gadea Grupo Farmacéutico, S.L.U. Business Overview

7.6.3 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.6.4 Gadea Grupo Farmacéutico, S.L.U. Finasteride API Products Offered

7.6.5 Gadea Grupo Farmacéutico, S.L.U. Recent Development

7.7 Hetero

7.7.1 Hetero Company Information

7.7.2 Hetero Business Overview

7.7.3 Hetero Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.7.4 Hetero Finasteride API Products Offered

7.7.5 Hetero Recent Development

7.8 Dr.Reddys Laboratories

7.8.1 Dr.Reddys Laboratories Company Information

7.8.2 Dr.Reddys Laboratories Business Overview

7.8.3 Dr.Reddys Laboratories Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.8.4 Dr.Reddys Laboratories Finasteride API Products Offered

7.8.5 Dr.Reddys Laboratories Recent Development

7.9 Pharmaffiliates

7.9.1 Pharmaffiliates Company Information

7.9.2 Pharmaffiliates Business Overview

7.9.3 Pharmaffiliates Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.9.4 Pharmaffiliates Finasteride API Products Offered

7.9.5 Pharmaffiliates Recent Development

7.10 Cipla

7.10.1 Cipla Company Information

7.10.2 Cipla Business Overview

7.10.3 Cipla Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.10.4 Cipla Finasteride API Products Offered

7.10.5 Cipla Recent Development

7.11 Henan Topfond

7.11.1 Henan Topfond Company Information

7.11.2 Henan Topfond Business Overview

7.11.3 Henan Topfond Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.11.4 Henan Topfond Finasteride API Products Offered

7.11.5 Henan Topfond Recent Development

7.12 Khonsu International

7.12.1 Khonsu International Company Information

7.12.2 Khonsu International Business Overview

7.12.3 Khonsu International Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.12.4 Khonsu International Finasteride API Products Offered

7.12.5 Khonsu International Recent Development

7.13 Aurobindo Pharma

7.13.1 Aurobindo Pharma Company Information

7.13.2 Aurobindo Pharma Business Overview

7.13.3 Aurobindo Pharma Finasteride API Sales, Revenue and Gross Margin (2020-2025)

7.13.4 Aurobindo Pharma Finasteride API Products Offered

7.13.5 Aurobindo Pharma Recent Development

8 Finasteride API Manufacturing Cost Analysis

8.1 Finasteride API Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Key Suppliers of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.3 Manufacturing Process Analysis of Finasteride API

8.4 Finasteride API Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

9.1 Marketing Channel

9.2 Finasteride API Distributors List

9.3 Finasteride API Customers

10 Finasteride API Market Dynamics

10.1 Finasteride API Industry Trends

10.2 Finasteride API Market Drivers

10.3 Finasteride API Market Challenges

10.4 Finasteride API Market Restraints

11 Research Findings and Conclusion

12 Appendix

12.1 Research Methodology

12.1.1 Methodology/Research Approach

12.1.1.1 Research Programs/Design

12.1.1.2 Market Size Estimation

12.1.1.3 Market Breakdown and Data Triangulation

12.1.2 Data Source

12.1.2.1 Secondary Sources

12.1.2.2 Primary Sources

12.2 Author Details

12.3 Disclaimer

TABLE OF FIGURES

List of Tables

Table 1. Global Finasteride API Sales (US$ Million) Growth Rate by Type (2020 & 2024 & 2031)

Table 2. Global Finasteride API Sales (US$ Million) Comparison by Application (2020 & 2024 & 2031)

Table 3. Global Market Finasteride API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Table 4. Global Finasteride API Sales (Tons) by Region (2020-2025)

Table 5. Global Finasteride API Sales Market Share by Region (2020-2025)

Table 6. Global Finasteride API Revenue (US$ Million) Market Share by Region (2020-2025)

Table 7. Global Finasteride API Revenue Share by Region (2020-2025)

Table 8. Global Finasteride API Sales (Tons) Forecast by Region (2026-2031)

Table 9. Global Finasteride API Sales Market Share Forecast by Region (2026-2031)

Table 10. Global Finasteride API Revenue (US$ Million) Forecast by Region (2026-2031)

Table 11. Global Finasteride API Revenue Share Forecast by Region (2026-2031)

Table 12. Global Finasteride API Sales by Type (Tons) & (2020-2025)

Table 13. Global Finasteride API Sales Share by Type (2020-2025)

Table 14. Global Finasteride API Revenue by Type (US$ Million) & (2020-2025)

Table 15. Global Finasteride API Price by Type (US$/Ton) & (2020-2025)

Table 16. Global Finasteride API Sales by Type (Tons) & (2026-2031)

Table 17. Global Finasteride API Revenue by Type (US$ Million) & (2026-2031)

Table 18. Global Finasteride API Price by Type (US$/Ton) & (2026-2031)

Table 19. Representative Players of Each Type

Table 20. Global Finasteride API Sales by Application (Tons) & (2020-2025)

Table 21. Global Finasteride API Sales Share by Application (2020-2025)

Table 22. Global Finasteride API Revenue by Application (US$ Million) & (2020-2025)

Table 23. Global Finasteride API Price by Application (US$/Ton) & (2020-2025)

Table 24. Global Finasteride API Sales by Application (Tons) & (2026-2031)

Table 25. Global Finasteride API Revenue Market Share by Application (US$ Million) & (2026-2031)

Table 26. Global Finasteride API Price by Application (US$/Ton) & (2026-2031)

Table 27. New Sources of Growth in Finasteride API Application

Table 28. Global Finasteride API Sales by Company (Tons) & (2020-2025)

Table 29. Global Finasteride API Sales Share by Company (2020-2025)

Table 30. Global Finasteride API Revenue by Company (US$ Million) & (2020-2025)

Table 31. Global Finasteride API Revenue Share by Company (2020-2025)

Table 32. Global Finasteride API by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Finasteride API as of 2024)

Table 33. Global Market Finasteride API Average Price by Company (US$/Ton) & (2020-2025)

Table 34. Global Key Manufacturers of Finasteride API, Manufacturing Sites & Headquarters

Table 35. Global Key Manufacturers of Finasteride API, Product Type & Application

Table 36. Global Key Manufacturers of Finasteride API, Date of Enter into This Industry

Table 37. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 38. North America Finasteride API Sales by Company (2020-2025) & (Tons)

Table 39. North America Finasteride API Sales Market Share by Company (2020-2025)

Table 40. North America Finasteride API Revenue by Company (2020-2025) & (US$ Million)

Table 41. North America Finasteride API Revenue Market Share by Company (2020-2025)

Table 42. North America Finasteride API Sales by Type (2020-2025) & (Tons)

Table 43. North America Finasteride API Sales Market Share by Type (2020-2025)

Table 44. North America Finasteride API Sales by Application (2020-2025) & (Tons)

Table 45. North America Finasteride API Sales Market Share by Application (2020-2025)

Table 46. Europe Finasteride API Sales by Company (2020-2025) & (Tons)

Table 47. Europe Finasteride API Sales Market Share by Company (2020-2025)

Table 48. Europe Finasteride API Revenue by Company (2020-2025) & (US$ Million)

Table 49. Europe Finasteride API Revenue Market Share by Company (2020-2025)

Table 50. Europe Finasteride API Sales by Type (2020-2025) & (Tons)

Table 51. Europe Finasteride API Sales Market Share by Type (2020-2025)

Table 52. Europe Finasteride API Sales by Application (2020-2025) & (Tons)

Table 53. Europe Finasteride API Sales Market Share by Application (2020-2025)

Table 54. China Finasteride API Sales by Company (2020-2025) & (Tons)

Table 55. China Finasteride API Sales Market Share by Company (2020-2025)

Table 56. China Finasteride API Revenue by Company (2020-2025) & (US$ Million)

Table 57. China Finasteride API Revenue Market Share by Company (2020-2025)

Table 58. China Finasteride API Sales by Type (2020-2025) & (Tons)

Table 59. China Finasteride API Sales Market Share by Type (2020-2025)

Table 60. China Finasteride API Sales by Application (2020-2025) & (Tons)

Table 61. China Finasteride API Sales Market Share by Application (2020-2025)

Table 62. Japan Finasteride API Sales by Company (2020-2025) & (Tons)

Table 63. Japan Finasteride API Sales Market Share by Company (2020-2025)

Table 64. Japan Finasteride API Revenue by Company (2020-2025) & (US$ Million)

Table 65. Japan Finasteride API Revenue Market Share by Company (2020-2025)

Table 66. Japan Finasteride API Sales by Type (2020-2025) & (Tons)

Table 67. Japan Finasteride API Sales Market Share by Type (2020-2025)

Table 68. Japan Finasteride API Sales by Application (2020-2025) & (Tons)

Table 69. Japan Finasteride API Sales Market Share by Application (2020-2025)

Table 70. AMRI Company Information

Table 71. AMRI Description and Business Overview

Table 72. AMRI Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 73. AMRI Finasteride API Product

Table 74. AMRI Recent Development

Table 75. Mylan Company Information

Table 76. Mylan Description and Business Overview

Table 77. Mylan Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 78. Mylan Finasteride API Product

Table 79. Mylan Recent Development

Table 80. Accord Pharmaceuticals Company Information

Table 81. Accord Pharmaceuticals Description and Business Overview

Table 82. Accord Pharmaceuticals Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 83. Accord Pharmaceuticals Finasteride API Product

Table 84. Accord Pharmaceuticals Recent Development

Table 85. Sterling Spa Company Information

Table 86. Sterling Spa Description and Business Overview

Table 87. Sterling Spa Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 88. Sterling Spa Finasteride API Product

Table 89. Sterling Spa Recent Development

Table 90. DEAFARMA Company Information

Table 91. DEAFARMA Description and Business Overview

Table 92. DEAFARMA Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 93. DEAFARMA Finasteride API Product

Table 94. DEAFARMA Recent Development

Table 95. Gadea Grupo Farmacéutico, S.L.U. Company Information

Table 96. Gadea Grupo Farmacéutico, S.L.U. Description and Business Overview

Table 97. Gadea Grupo Farmacéutico, S.L.U. Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 98. Gadea Grupo Farmacéutico, S.L.U. Finasteride API Product

Table 99. Gadea Grupo Farmacéutico, S.L.U. Recent Development

Table 100. Hetero Company Information

Table 101. Hetero Description and Business Overview

Table 102. Hetero Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 103. Hetero Finasteride API Product

Table 104. Hetero Recent Development

Table 105. Dr.Reddys Laboratories Company Information

Table 106. Dr.Reddys Laboratories Description and Business Overview

Table 107. Dr.Reddys Laboratories Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 108. Dr.Reddys Laboratories Finasteride API Product

Table 109. Dr.Reddys Laboratories Recent Development

Table 110. Pharmaffiliates Company Information

Table 111. Pharmaffiliates Description and Business Overview

Table 112. Pharmaffiliates Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 113. Pharmaffiliates Finasteride API Product

Table 114. Pharmaffiliates Recent Development

Table 115. Cipla Company Information

Table 116. Cipla Description and Business Overview

Table 117. Cipla Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 118. Cipla Finasteride API Product

Table 119. Cipla Recent Development

Table 120. Henan Topfond Company Information

Table 121. Henan Topfond Description and Business Overview

Table 122. Henan Topfond Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 123. Henan Topfond Finasteride API Product

Table 124. Henan Topfond Recent Development

Table 125. Khonsu International Company Information

Table 126. Khonsu International Description and Business Overview

Table 127. Khonsu International Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 128. Khonsu International Finasteride API Product

Table 129. Khonsu International Recent Development

Table 130. Aurobindo Pharma Company Information

Table 131. Aurobindo Pharma Description and Business Overview

Table 132. Aurobindo Pharma Finasteride API Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2020-2025)

Table 133. Aurobindo Pharma Finasteride API Product

Table 134. Aurobindo Pharma Recent Development

Table 135. Production Base and Market Concentration Rate of Raw Material

Table 136. Key Suppliers of Raw Materials

Table 137. Finasteride API Distributors List

Table 138. Finasteride API Customers List

Table 139. Finasteride API Market Trends

Table 140. Finasteride API Market Drivers

Table 141. Finasteride API Market Challenges

Table 142. Finasteride API Market Restraints

Table 143. Research Programs/Design for This Report

Table 144. Key Data Information from Secondary Sources

Table 145. Key Data Information from Primary Sources

List of Figures

Figure 1. Finasteride API Product Picture

Figure 2. Global Finasteride API Sales (US$ Million) by Type (2020 & 2024 & 2031)

Figure 3. Global Finasteride API Sales Market Share by Type in 2024 & 2031

Figure 4. Abrove 99% Purity Product Picture

Figure 5. 99% Purity Product Picture

Figure 6. Under 99% Purity Product Picture

Figure 7. Global Finasteride API Sales (US$ Million) by Application (2020 & 2024 & 2031)

Figure 8. Global Finasteride API Sales Market Share by Application in 2024 & 2031

Figure 9. Pharmaceutical Industry Examples

Figure 10. Research Organization Examples

Figure 11. Others Examples

Figure 12. Global Finasteride API Sales, (US$ Million), 2020 VS 2024 VS 2031

Figure 13. Global Finasteride API Sales Growth Rate (2020-2031) & (US$ Million)

Figure 14. Global Finasteride API Sales (Tons) Growth Rate (2020-2031)

Figure 15. Global Finasteride API Price Trends Growth Rate (2020-2031) & (US$/Ton)

Figure 16. Finasteride API Report Years Considered

Figure 17. Global Market Finasteride API Market Size (US$ Million) by Region:2020 VS 2024 VS 2031

Figure 18. Global Finasteride API Revenue Market Share by Region: 2020 VS 2024

Figure 19. North America Finasteride API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 20. North America Finasteride API Sales (Tons) Growth Rate (2020-2031)

Figure 21. Europe Finasteride API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 22. Europe Finasteride API Sales (Tons) Growth Rate (2020-2031)

Figure 23. China Finasteride API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 24. China Finasteride API Sales (Tons) Growth Rate (2020-2031)

Figure 25. Japan Finasteride API Revenue (US$ Million) Growth Rate (2020-2031)

Figure 26. Japan Finasteride API Sales (Tons) Growth Rate (2020-2031)

Figure 27. Global Finasteride API Revenue Share by Type (2020-2025)

Figure 28. Global Finasteride API Sales Share by Type (2026-2031)

Figure 29. Global Finasteride API Revenue Share by Type (2026-2031)

Figure 30. Global Finasteride API Revenue Share by Application (2020-2025)

Figure 31. Global Finasteride API Revenue Growth Rate by Application in 2020 & 2024

Figure 32. Global Finasteride API Sales Share by Application (2026-2031)

Figure 33. Global Finasteride API Revenue Share by Application (2026-2031)

Figure 34. Global Finasteride API Sales Share by Company (2024)

Figure 35. Global Finasteride API Revenue Share by Company (2024)

Figure 36. Global 5 Largest Finasteride API Players Market Share by Revenue in Finasteride API: 2020 & 2024

Figure 37. Finasteride API Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 38. Manufacturing Cost Structure of Finasteride API

Figure 39. Manufacturing Process Analysis of Finasteride API

Figure 40. Finasteride API Industrial Chain

Figure 41. Channels of Distribution (Direct Vs Distribution)

Figure 42. Distributors Profiles

Figure 43. Bottom-up and Top-down Approaches for This Report

Figure 44. Data Triangulation

Figure 45. Key Executives Interviewed

KEY QUESTIONS ADDRESSED BY THE REPORT

Which companies rank high in the global Finasteride API market? zhanKai

The top companies in the global Finasteride API market are AMRI、Mylan、Accord Pharmaceuticals.

Related Reports

Finasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Finasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-07-14
Pages: 137
USD 3950.00
(Single User License)
Global Finasteride API Market Research Report 2026
The global Finasteride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-04-21
Pages: 137
USD 2900.00
(Single User License)
Global Finasteride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Finasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-10-22
Pages: 154
USD 4900.00
(Single User License)
Finasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Finasteride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-02-15
Pages: 123
USD 3950.00
(Single User License)
Global Finasteride API Market Research Report 2025
The global market for Finasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-02-15
Pages: 99
USD 2900.00
(Single User License)
Global Finasteride API Market Insights, Forecast to 2030
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published Date: 2024-04-07
Pages: 111
USD 4900.00
(Single User License)
Finasteride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published Date: 2024-02-19
Pages: 122
USD 3950.00
(Single User License)
Global Finasteride API Market Research Report 2024
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published Date: 2024-01-11
Pages: 97
USD 2900.00
(Single User License)

Finasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Finasteride API was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-07-14
Pages: 137
USD 3950.00 (Single User License)
Global Finasteride API Market Research Report 2026
The global Finasteride API market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-04-21
Pages: 137
USD 2900.00 (Single User License)
Global Finasteride API Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Finasteride API market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-10-22
Pages: 154
USD 4900.00 (Single User License)
Finasteride API- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Finasteride API was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-02-15
Pages: 123
USD 3950.00 (Single User License)
Global Finasteride API Market Research Report 2025
The global market for Finasteride API was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-02-15
Pages: 99
USD 2900.00 (Single User License)
Global Finasteride API Market Insights, Forecast to 2030
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published: 2024-04-07
Pages: 111
USD 4900.00 (Single User License)
Finasteride API - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published: 2024-02-19
Pages: 122
USD 3950.00 (Single User License)
Global Finasteride API Market Research Report 2024
Finasteride API is a 5α-reductase inhibitor and therefore an antiandrogen.[9] It works by decreasing the production of dihydrotestosterone (DHT) by about 70%, including in the prostate gland and the scalp.
Published: 2024-01-11
Pages: 97
USD 2900.00 (Single User License)